Redx to receive $3.5 million upfront, up to $203 million in milestone payments and royalty payments
Redx Pharma plc (LON:REDX) Sale of pan-RAF inhibitor programme
Kunwar Shailubhai, CEO of Tiziana Life Sciences (NASDAQ:TLSA, AIM:TILS) Interview
Zak Mir speaks with Kunwar Shailubhai, CEO of Tiziana Life Sciences, are the markets, prospective investor understanding the business model?. As is often the case the focus is on a company
